Genentech Acquires Seragon Pharmaceuticals for $1,725,000,000

  • Feed Type
  • Date
    7/2/2014
  • Company Name
    Seragon Pharmaceuticals
  • Mailing Address
    12780 El Camino Real San Diego, CA 92130 USA
  • Company Description
    Seragon Pharmaceuticals is developing small-molecule drugs for the treatment of estrogen receptor dependent breast cancer.
  • Website
    http://www.seragonpharm.com
  • Transaction Type
    M&A
  • Transaction Amount
    $1,725,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Under the terms of the agreement, Genentech will make an upfront cash payment of $725 million, plus additional contingent payments of up to $1 billion based on achievement of certain predetermined milestones.

Trending on Xconomy